Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence G Lum

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 3, 2017
Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipientsDipenkumar Modi, Hyejeong Jang, Seongho Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2015
Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical TrialLawrence G Lum, Archana Thakur, Zaid Al-Kadhimi, et al.
Journal of Neuro-Oncology|January 24, 2024
Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomideCamilo E Fadul, Archana Thakur, Jungeun Kim, et al.
Blood Cells, Molecules & Diseases|February 6, 2004
Differentiation hotspots: the deterioration of hierarchy and stochasmGerald A Colvin, Jean-Francois Lambert, M Abedi, et al.
Transactions of the American Clinical and Climatological Association|June 11, 2002
The new stem cell biologyPeter J Quesenberry, Gerald A Colvin, Jean-Francois Lambert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2022
Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate CancerUlka N Vaishampayan, Archana Thakur, Wei Chen, et al.
Frontiers in Immunology|August 30, 2023
Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activityMary L Faber, Robyn A A Oldham, Archana Thakur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical studyJohn K Chan, Chad A Hamilton, Michael K Cheung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2016
Targeting CD138-/CD20+ Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma ImmunityLawrence G Lum, Archana Thakur, Sri Vidya Kondadasula, et al.
Research Square|November 21, 2023
Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cellsMaxim Yankelevich, Archana Thakur, Shakeel Modak, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 3, 2017
Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipientsDipenkumar Modi, Hyejeong Jang, Seongho Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2015
Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical TrialLawrence G Lum, Archana Thakur, Zaid Al-Kadhimi, et al.
Journal of Neuro-Oncology|January 24, 2024
Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomideCamilo E Fadul, Archana Thakur, Jungeun Kim, et al.
Blood Cells, Molecules & Diseases|February 6, 2004
Differentiation hotspots: the deterioration of hierarchy and stochasmGerald A Colvin, Jean-Francois Lambert, M Abedi, et al.
Transactions of the American Clinical and Climatological Association|June 11, 2002
The new stem cell biologyPeter J Quesenberry, Gerald A Colvin, Jean-Francois Lambert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2022
Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate CancerUlka N Vaishampayan, Archana Thakur, Wei Chen, et al.
Frontiers in Immunology|August 30, 2023
Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activityMary L Faber, Robyn A A Oldham, Archana Thakur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical studyJohn K Chan, Chad A Hamilton, Michael K Cheung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2016
Targeting CD138-/CD20+ Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma ImmunityLawrence G Lum, Archana Thakur, Sri Vidya Kondadasula, et al.
Research Square|November 21, 2023
Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cellsMaxim Yankelevich, Archana Thakur, Shakeel Modak, et al.
Pageof 9